Fig. 2 (IMAGE) Osaka University Caption (A) When recombinant RSPO3 was administered intracerebroventricularly one day after the stroke, the neurological deficit was reduced. (B) Neurite outgrowth was promoted in primary neuronal cells cultured in medium containing RSPO3. (C) RSPO3 suppressed the expression of inflammatory cytokines in LPS-stimulated microglia. Credit Modified from Stroke Usage Restrictions No restrictions. License CC0 Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.